http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kim |
| name | Tae-You Kim |
| given-name | Tae-You |
| organization-name | Cancer Research Institute, Departments of Molecular and Clinical Oncology; Tumor Biology, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 110-799, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea 1National Research Laboratory for Cancer Epigenetics, Cancer Research Institute and; 2Department of Internal Medicine, Seoul National University College of Medicine, Chongno, Seoul, Republic of Korea 1Department of Internal Medicine,; 2Cancer Research Institute, and; 4Department of Internal Medicine and Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; 7Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 1National Research Laboratory for Cancer Epigenetics, Cancer Research Institute,; 2Department of Tumor Biology, and; 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. 1Department of Biochemistry and Molecular Biology and University of Florida Shands Cancer Center Program in Cancer Genetics, Epigenetics, and Tumor Virology, and Seoul National University Cancer Hospital, Seoul, South Korea. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea;; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea 1Department of Biochemistry and Molecular Biology and University of Florida Shands Cancer Center Program in Cancer Genetics, Epigenetics, and Tumor Virology, University of Florida College of Medicine, Gainesville, Florida;; 2Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine; and Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; WCU Molecular Medicine & Biopharmaceutical Science, Seoul National University College of Medicine, Seoul, Korea. From the Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea; and Departments of Radiology and Pathology, Seoul National University College of Medicine, Seoul, Korea. Authors' Affiliations: Departments of 1Pharmacology, 2Physiology, and 3Internal Medicine, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea. 1Department of Internal Medicine and; 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Brigham and Womens Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115; and; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, South Korea Cancer Research Institute, Seoul National University, Jongno-gu, Seoul, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Yeongtong-gu, Suwon-si, South Korea kimty@snu.ac.kr. From the Department of Internal Medicine, Department of Pathology, and Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital; Department of Internal Medicine, Seoul Municipal Boramae Hospital; Department of Internal Medicine, Seoul National University Bundang Hospital; Cancer Research Institute, Seoul National University College of Medicine; Petagen Inc, Seoul, Korea Departments of Internal Medicine, Seoul National University College of Medicine Seoul National University Hospital, Seoul, South Korea Department of Neurology, Willis Hospital, Pusan, Korea Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea Authors' Affiliations: 1Cancer Research Institute, 2Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Jongno-gu, Seoul, Korea; and Departments of 3Translational Research and 4Computational Biology, Oncology Research Unit, Pfizer, Inc., La Jolla, California; Authors' Affiliations: 1Cancer Research Institute, 2Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Jongno-gu, Seoul, Korea; and Departments of 3Translational Research and 4Computational Biology, Oncology Research Unit, Pfizer, Inc., La Jolla, California 1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea; 1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea; 1Cancer Research Institute, 2Department of Internal Medicine, College of Medicine, and 3Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-744, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea Authors' Affiliations: 1Cancer Research Institute; 2Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; and 3AstraZeneca, Alderly Park, Mcclesfield, Cheshire, United Kingdom; Authors' Affiliations: 1Cancer Research Institute; 2Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; and 3AstraZeneca, Alderly Park, Mcclesfield, Cheshire, United Kingdom 1Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; 3Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea;; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea Cancer Genomics Research Laboratory, Cancer Research Institute, Seoul National University, Seoul 03080, Republic of Korea; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 03080, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea IMBdx Inc., Seoul 08506, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea; Cancer Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.; Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea. 1Department of Internal Medicine, and 1Internal Medicine and Departments of; 3Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-744, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea. 1Cancer Research Institute,; 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Department of Internal Medicine 1 , 2 , and 3; Department of Pathology 1 , 2 , and 3; Department of Surgery, Seoul National University Hospital, Seoul 110-744, Korea 1 , 2 , and 3; Cancer Research Institute 7 ; 8 ; and 9; Genomic Medicine Institute, Medical Research Center 7 ; 8 ; and 9; Department of Biochemistry, Seoul National University College of Medicine, Seoul 120-799, Korea 7 ; 8 ; and 9; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 151-742, Korea 11 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; 4Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Internal Medicine, Seoul National University College of Medicine, Jongno-gu 1National Research Laboratory for Cancer Epigenetics, Cancer Research Institute; Departments of; 2Tumor Biology and; 3Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; and Seoul National University, Seoul, South Korea Department of Internal Medicine, Seoul National University, Seoul, South Korea In2Gen Co., Ltd., 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea, Life Science Research Center, SK Chemicals, 600 Jungja-dong, Changan-gu, Suwon, Kyungki-do 440-745, Korea, College of Pharmacy, Sungkyunkwan University, Suwon, Kyungki-do 440-746, Korea, and National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea Authors' Affiliations: 1Cancer Research Institute, Seoul National University; Departments of 2Internal Medicine and 3Pathology, Seoul National University College of Medicine; 4Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Republic of Korea; and 5AstraZeneca UK Ltd., Macclesfield, Cheshire, United Kingdom; Authors' Affiliations: 1Cancer Research Institute, Seoul National University; Departments of 2Internal Medicine and 3Pathology, Seoul National University College of Medicine; 4Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Republic of Korea; and 5AstraZeneca UK Ltd., Macclesfield, Cheshire, United Kingdom; Authors' Affiliations: 1Cancer Research Institute, Seoul National University; Departments of 2Internal Medicine and 3Pathology, Seoul National University College of Medicine; 4Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Republic of Korea; and 5AstraZeneca UK Ltd., Macclesfield, Cheshire, United Kingdom Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. |
Incoming Links
Total number of triples: 377.